Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
21st March 2019
This year marks 25 years with the practice for Lesley Kerr and Heather Grandon. The loyal and dependable duo have been at the heart of the practice for a quarter century, a period when the practice ha...Read more
27th February 2019
We are delighted to welcome Hemp Eyewear to the Frame Room this month. Proudly unconventional: the materials, the process, the design and the look. This is such an exciting brand on so many levels. ...Read more
19th February 2019
Heather Muir and Heather Grandon headed south to Hemel Hempstead to Cantor & Nissel, the company we use to manufacturer cosmetic lenses for our patients. We have used the company for many years, c...Read more